147
Participants
Start Date
January 31, 2006
Primary Completion Date
April 30, 2008
Study Completion Date
June 30, 2008
placebo
5 days of 28 day cycle for 2 cycles
A007
5 days of 28 day cycle
New York Downtown Hospital, New York
Jacobi Medical Center, The Bronx
Montefiore Medical Center-Weiler Division Dept of OB/GYN & Women's Health, The Bronx
Magee-Womens Hospital, Dept of OB/GYN & Reproductive Services, Pittsburgh
Lehigh Valley Hospital, Allentown
Washington Hospital Center, Washington D.C.
South Carolina Oncology Associates, Columbia
Mount Vernon Clinical Research, LLC, Atlanta
Medical College of Georgia, Augusta
Global OB/GYN Centers of Florida, Pembroke Pines
OB/GYN Specialists of the Palm Beaches, West Palm Beach
Visions Clinical Research, Boynton Beach
Physician Care Clinical Research, LLC., Sarasota
University of Alabama Highlands, Dept. of OB/GYN, Birmingham
Greater Cincinnati OB/GYN, Inc., Cincinnati
East Jefferson OB/GYN, Metairie
University of Oklahoma Health Sciences Center Dept of OB/GYN, Oklahoma City
4601 Old Shepard Place; Bldg 2, Suite 201, Plano
Planned Parenthood of Houston & Southeast Texas, Inc., Houston
Hill Country OB/GYN, Austin
Hope Research Institute, LLC, Phoenix
Visions Clinical Research-Tucson, Tucson
Office of R. Garn Mabey, MD, Las Vegas
IGO Medical Group of San Diego, San Diego
Arrowhead Regional Medical Center, Colton
Robin Black OGNP, Costa Mesa
Northern California Research Corp, Carmichael
Coastal Connecticut Research, LLC, New London
Jersey Shore University Medical Center, Neptune City
Lead Sponsor
Tigris Pharmaceuticals
INDUSTRY